Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

During the Trading Day
49.63 +2.58 / +5.48%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
49.63 0.00 / 0.00%
Volume: 11.2K
Health Technology

Company Description

Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company, which discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Contact Information

Neurocrine Biosciences, Inc.
12780 El Camino Real
San Diego California 92130
P:(858) 617-7600
Investor Relations:



Individual stakeholders8.66%
Mutual fund holders63.96%
Other institutional33.79%

Top Executives

Kevin Charles GormanPresident, Chief Executive Officer & Director
Bill WilsonVice President-Information Technology & Operations
Timothy P. CoughlinChief Financial Officer
Dimitri E. GrigoriadisChief Research Officer
Christopher Flint O'BrienChief Medical Officer